The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
This technology is the first to show that subcutaneous administrations of chitosan and an appropriate antigen, with no other component, can be used for enhancing immune responses. More
Peptides and antigen epitopes specific for RCC for use in the diagnosis, vaccination, or adoptive infusion of antigen specific T cells to treat patients with metastatic RCC More
These compositions may represent potential anticancer therapeutics, stimulating NY ESO-1/CAG-3-specific T cells to elicit an anti-cancer immunogenic response and thereby eliminating or reducing the cancer. More
A method of identifying a ligand as a candidate for incorporation into a pharmaceutical composition that modulates antigen presenting cell activity More
The agent that blocks the TGF-beta signaling pathway may inhibit the immunosuppressive effects of TGF-beta, while the immunogenic agent is believed to enhance an immune response. More
Displaying 1..10 of 22 -
per page
Next page
Order by
All rights reserved. Terms and Conditions | Contact us
